Company / Current Assets per Share
Cytokinetics Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$7634.91
FY2025
5-year range
$6.32 / $7634.91
FY2021-FY2025
Trend
+69939.5%
vs FY2024
Sector context
#2 of 210
Health Care
What the data says
Current Assets per Share changed +69940% YoY in FY2025, a notable deviation from the 9-year average annual change of +7788%.
Based on SEC 10-K filings.
7634.91 in FY2025 with a 5-year CAGR of +308.9%. Ranks 2nd among 210 companies in Health Care.
Improved from $6.62 to $7634.91 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +833.8%
- 5-Year CAGR
- +308.9%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 210This company $7634.91 Sector average $170.65
▼
+4374.1% above sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 69939.5% year-over-year.
- Ranks #2 out of 210 companies in the Health Care sector.
- Lowest current assets per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7634.91 | +69939.5% |
| FY2024 | $10.90 | +64.6% |
| FY2023 | $6.62 | -29.4% |
| FY2022 | $9.38 | +48.4% |
| FY2021 | $6.32 | -5.4% |
| FY2020 | $6.68 | +69.0% |
| FY2019 | $3.95 | +4.1% |
| FY2018 | $3.80 | -25.3% |
| FY2017 | $5.08 | +30.2% |
| FY2016 | $3.90 | +36.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026